Anavex Historical Income Statement
AVXL Stock | USD 3.76 0.07 1.90% |
Historical analysis of Anavex Life income statement accounts such as Other Operating Expenses of 67.3 M, Total Operating Expenses of 67.3 M or Depreciation And Amortization of 5.2 M can show how well Anavex Life Sciences performed in making a profits. Evaluating Anavex Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Anavex Life's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Anavex Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anavex Life Sciences is a good buy for the upcoming year.
Anavex |
About Anavex Income Statement Analysis
Anavex Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Anavex Life shareholders. The income statement also shows Anavex investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Anavex Life Income Statement Chart
Anavex Life Sciences Income Statement is one of the three primary financial statements used for reporting Anavex's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Anavex Life Sciences revenue and expense. Anavex Life Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Research Development is expected to rise to about 52.8 M this year, although the value of EBIT is projected to rise to (40.6 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Anavex Life Sciences. It is also known as Anavex Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Anavex Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Research Development is expected to rise to about 52.8 M this year, although the value of EBIT is projected to rise to (40.6 M).
2021 | 2022 | 2023 | 2024 (projected) | Tax Provision | 358.5K | 7K | 8.1K | 7.6K | Interest Income | 947.0K | 6.5M | 7.5M | 7.9M |
Anavex Life income statement Correlations
Click cells to compare fundamentals
Anavex Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anavex Life income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 4.8M | 4.0M | 947.0K | 964K | 1.1M | 1.3M | |
Other Operating Expenses | 30.9M | 41.9M | 51.0M | 55.8M | 64.1M | 67.3M | |
Operating Income | (30.8M) | (41.9M) | (54.4M) | (47.5M) | (42.7M) | (40.6M) | |
Ebit | (30.8M) | (41.9M) | (54.4M) | (47.5M) | (42.7M) | (40.6M) | |
Ebitda | (31.1M) | (41.7M) | (50.1M) | (47.5M) | (42.7M) | (40.6M) | |
Total Operating Expenses | 30.9M | 41.9M | 51.0M | 55.8M | 64.1M | 67.3M | |
Net Income | (26.3M) | (37.9M) | (48.0M) | (47.5M) | (42.7M) | (40.6M) | |
Income Tax Expense | 22.7K | 267.6K | 358.5K | (7K) | (6.3K) | (6.0K) | |
Depreciation And Amortization | (129.5K) | (305.5K) | 241.1K | 4.3M | 5.0M | 5.2M | |
Income Before Tax | (26.3M) | (37.6M) | (47.6M) | (47.5M) | (42.7M) | (40.6M) | |
Total Other Income Expense Net | 4.5M | 4.3M | 6.8M | 2.7M | 3.1M | 3.2M | |
Selling General Administrative | 5.9M | 9.0M | 13.1M | 12.0M | 13.8M | 14.5M | |
Research Development | 25.2M | 33.0M | 37.9M | 43.7M | 50.3M | 52.8M | |
Net Income From Continuing Ops | (26.3M) | (37.9M) | (48.0M) | (47.5M) | (42.8M) | (40.6M) | |
Non Operating Income Net Other | 2.7M | 4.7M | 4.3M | 2.4M | 2.8M | 2.9M | |
Net Income Applicable To Common Shares | (26.3M) | (37.9M) | (48.0M) | (47.5M) | (42.8M) | (40.6M) | |
Interest Income | 180.0K | 26.3K | 947.0K | 6.5M | 7.5M | 7.9M | |
Tax Provision | 22.7K | 267.6K | 358.5K | 7K | 8.1K | 7.6K | |
Net Interest Income | 180.0K | 26.3K | 947.0K | 5.6M | 6.4M | 6.7M |
Pair Trading with Anavex Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anavex Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anavex Life will appreciate offsetting losses from the drop in the long position's value.Moving together with Anavex Stock
0.87 | EVOK | Evoke Pharma | PairCorr |
0.64 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
Moving against Anavex Stock
0.64 | ELYM | Eliem Therapeutics Trending | PairCorr |
0.62 | JAGX | Jaguar Animal Health Financial Report 20th of May 2024 | PairCorr |
0.59 | VKTX | Viking Therapeutics | PairCorr |
0.59 | OGN | Organon | PairCorr |
0.57 | HCWB | HCW Biologics | PairCorr |
The ability to find closely correlated positions to Anavex Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anavex Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anavex Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anavex Life Sciences to buy it.
The correlation of Anavex Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anavex Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anavex Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anavex Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Anavex Stock analysis
When running Anavex Life's price analysis, check to measure Anavex Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anavex Life is operating at the current time. Most of Anavex Life's value examination focuses on studying past and present price action to predict the probability of Anavex Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anavex Life's price. Additionally, you may evaluate how the addition of Anavex Life to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Anavex Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Return On Assets (0.21) | Return On Equity (0.32) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.